Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BIO Notebook Day 3: ARM Launches Foundation To Educate Public About Gene And Cell Therapies

Executive Summary

Alliance for Regenerative Medicine initiative seeks to explain gene and cell therapy to the general public. Also, EY's Giovannetti says strategic decisions, not tax reform, should drive deal-making; FDA's Woodcock touts benefits of new drug review office overhaul; and Siga Technologies eyes priority review voucher upon approval of Tpoxx for smallpox.

Advertisement

Related Content

Another Reorg For US FDA Drug Office: Dispute Resolution Program Moves Out
BIO Notebook Day 2: Levin Scolds Industry For Squandering Proceeds From US Tax Reform
Office Of New Drugs Reorg Is Bigger Than Expected: US FDA Adds 11 Review Divisions
Takeda Poised To Move Into Pharma Top 10 With Shire Combination
Animals Rule: SIGA’s Smallpox Drug Tecovirimat Sails Through US FDA Panel
Priority Review Voucher Crash: Spark's Sale To Jazz Lowest Price Since 2014
SIGA’s Smallpox Drug Tecovirimat Looks Primed For Smooth US FDA Panel Review
Celgene Seeks CAR-T Leadership, Hematology Diversification With Juno Buy
Sanofi Builds Blood Disorder Specialty With Bioverativ Buy

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS123245

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel